The benefit-cost ratio and net benefit were 0.91 and –$336, respectively, for all members and 1.43 and $2337, respectively, for members adherent to sacubitril/valsartan.

Conservatives support cost-benefit analysis when it slows progressive regulation but abandon it when it stands in the way of their deregulatory agenda. For the past 40 years, the process by which ...

It is increasingly maintained that cost—benefit analysis (CBA) should play a greater role in educational policy-making. This article critically examines the rationale guiding CBA and its compatibility ...

That isn’t what benefit-cost analysis—required by presidents for more than 40 years and increasingly by courts—is supposed to do.

Under the Trump administration, the Securities and Exchange Commission is in the process of revamping its approach to the cost-benefit analysis ...

Using a cost-benefit analysis, I assess whether it is optimal for the United States to follow the lead of many European countries and introduce a nation-wide lockdown.

Cost-benefit analysis is rigged to favor industry and breathtakingly easy to manipulate — vastly overcounting the costs and undercounting the benefits of proposed safeguards.

Biden’s regulatory changes should consider who benefits from cost-benefit analysis by Matthew D. Adler and Alex Raskolnikov - 04/29/21 12:01 PM ET Getty Images ...

The Center for Benefit-Cost Studies of Education specializes in calculating and comparing the long- and short-term costs—and probable payoffs—of different educational strategies that promise ...

Q&A Cost-Benefit Analysis of Expected SEC Disclosure Rules Leaves Questions for Attorneys and Clients Anticipated SEC Scope 1 to 3 emission disclosure rules may—at least in part—fall short of ...